April 26, 2024

Cutting-edge diabetes technology showcased at DPC – The Diabetes Times

0

Pioneering technology that is improving the lives of people with diabetes will take centre stage at this year’s DPC.

The conference, which returns as an in-person event at Olympia London on 10 and 11 November, includes a dedicated Technology and Innovation Zone, where the latest…….

Pioneering technology that is improving the lives of people with diabetes will take centre stage at this year’s DPC.

The conference, which returns as an in-person event at Olympia London on 10 and 11 November, includes a dedicated Technology and Innovation Zone, where the latest diabetes products will be showcased in conjunction with a series of expert talks and demonstrations about how such technology is put into practice and the impact it is having.

Product exhibitions include:

BlueDop

BlueDop is a trailblazing new product which detects vascular disease and offers an innovative, cuffless alternative to traditional ABpI tests. Delegates will have the opportunity to test the BlueDop Vascular Expert, a software system which converts a digital doppler signal into a blood pressure reading.

BlueDop negates the need for the traditional use of a cuff on lower limbs, a process which can be time-consuming and inaccurate as up to 30% of those being tested have diabetes and do not respond to blood pressure cuffs because of ulceration and incompressible arteries.

ARKRAY’S The Lab 001

The Lab 001 uses cutting-edge technology to provide HbA1c results in just 90 seconds. This latest diabetes testing technology – the fastest of its kind – is now being supplied directly to the UK by Japanese company ARKRAY, a global pioneer in diabetes innovation for more than 60 years.

The Lab 001 uses capillary electrophoresis technology in a compact device, providing high-quality HbA1c results while dramatically reducing patients’ wait time. A simple fingerpick sample can be used for measurement and the electropherogram generated indicates the HbA1c value along with any clinically significant variants.

MySugarWatch®

MySugarWatch® is needle-free continuous glucose monitoring – every five minutes for type 2 diabetes. The MySugarWatch® daily sensor sits comfortably on, not under, the skin, monitoring glucose levels in real time without repeated scanning, and avoiding time consuming, repeated fingerprick tests at work. It allows people with diabetes to track their highs and lows, identify trends and monitor their time in range.

Academy

Academy is a free educational platform where healthcare professionals can increase their knowledge in diabetes technologies. It was developed by Glooko, a provider of diabetes digital health solutions, in collaboration with the Association of British Clinical Diabetologists (ABCD) and Diabetes Technology Network UK (DTN-UK), supported by major companies committed to improving diabetes care.

Academy focuses exclusively on diabetes health tech, data management and remote patient monitoring (RPM), to help clinicians keep their knowledge base current and to increase training. Courses include continuous glucose monitoring, diabetes technology in pregnancy and self-monitoring blood glucose.

The Edge at DPC

The Edge at …….

Source: https://diabetestimes.co.uk/cutting-edge-diabetes-technology-showcased-at-dpc/

Leave a Reply

Your email address will not be published. Required fields are marked *